For decades, adiponectin was known as the “Guardian angel” adipocytokine [29,42] since it has been shown to play a central role in preventing and protecting against the development of multiple disorders related to obesity, especially in metabolic syndromes, diabetes, cardiovascular diseases, inflammation, and cancers. This evidence concerns the gene ADIPOQ and diabetes mellitus.